Related Experiment Videos
How does autoimmunity to La and Ro initiate and spread?
1Department of Clinical Immunology, Flinders Medical Centre, Bedford Park, South Australia.
Autoimmunity
|January 1, 1994
Summary
Autoimmunity to La (SS-B) and Ro (SS-A) ribonucleoproteins offers insights into B and T cell tolerance. A model suggests B cells capturing these antigens can initiate autoimmune responses, explaining Sjögren
Area of Science:
- Immunology
- Autoimmunity Research
- Molecular Biology
Background:
- Autoimmunity to La (SS-B) and Ro (SS-A) is crucial for understanding B and T cell tolerance.
- The selection of these specific autoantigens remains unclear.
- Abnormal antigen presentation or release from injured epithelial cells may target salivary and lacrimal glands in Sjögren's syndrome.
Purpose of the Study:
- To investigate the mechanisms behind autoimmunity targeting La (SS-B) and Ro (SS-A) antigens.
- To elucidate the reasons for the selection of these specific autoantigens in autoimmune responses.
- To propose a model explaining the development and spreading of autoimmunity to La/Ro ribonucleoproteins.
Main Methods:
- Epitope mapping experiments were utilized to analyze autoantibody responses.
- The study discusses potential mechanisms involving peptide trafficking in epithelial cells.
- A model of recruited autoimmunity is presented based on B cell antigen capture and presentation.
Main Results:
- Autoantibody responses are largely self antigen-driven, but the selection mechanism is not fully understood.
- Limited immune tolerance to La antigen in T helper and B cell compartments was observed.
- Both intra- and inter-molecular spreading of the autoimmune response to La have been documented.
Conclusions:
- Abnormal trafficking or release of La/Ro ribonucleoproteins may explain Sjögren's syndrome pathogenesis.
- A model of recruited autoimmunity proposes that B cell uptake and presentation of La/Ro can drive inter-molecular epitope spreading.
- Further research is needed to fully understand the initiation and progression of autoimmunity to these sequestered antigens.